(Press-News.org) Alzheimer's disease (AD) is a growing challenge to the health care systems and economies of developed countries with millions of patients suffering from this disease and increasing numbers of new cases diagnosed annually with the increasing ageing of populations.
Early detection of prodromal AD is vital both for assessing the efficacy of potential AD therapeutic agents as well as new disease modifying therapies are most likely to be effective when initiated during the early stages of disease. The elucidation of early metabolic pathways associated with progression to Alzheimer's disease may also help in identifying new therapeutic avenues.
In 2010 GE Healthcare entered into "biosignatures initiative" alliance with Janssen Pharmaceutica N.V. (Janssen) to develop diagnostic biosignatures for pre-symptomatic identification of AD. As part of this programme, VTT will apply serum metabolite profiling to validate their recently discovered biochemical signature, as well as to discover novel biomarker candidates predictive of progression to AD.
VTT's research professor Matej Orešič said: "We are excited about the prospect of collaborating with GE Healthcare to accelerate its research programs and to further develop our biomarker towards a clinical assay applicable in healthcare setting. VTT has over the past years built unique metabolomics and systems biology platforms and acquired vast amount of knowledge on metabolic profiles and pathways in human health and disease, which allow us to identify disease-specific biochemical signatures and pathways. We believe that integration of metabolomics into the GE's and Janssen's biosignatures initiative will lead to better tools for early detection of AD and may also lead to better therapeutic options."
###
Further information:
VTT Technical Research Centre of Finland
Sampo Sammalisto, Key Account Manager
tel. +358 50 584 1100, sampo.sammalisto@vtt.fi
VTT Technical Research Centre of Finland
Matej Orešič, Research Professor
tel. +358 40 705 5156, matej.oresic@vtt.fi
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. For more information about GE Healthcare, visit: www.gehealthcare.com.
About VTT Technical Research Centre of Finland
VTT is a leading multitechnological applied research organization in Northern Europe. It creates new technology and science-based innovations in co-operation with domestic and foreign partners. VTT's turnover is EUR 290 million and its personnel totals 3,100. For further information, visit www.vtt.fi
Further information on VTT:
Sakari Sohlberg, Manager, External Communications
Tel. 358 20 722 6744
sakari.sohlberg@vtt.fi
www.vtt.fi
VTT and GE Healthcare developing novel biomarkers to predict Alzheimer's disease
2012-09-17
ELSE PRESS RELEASES FROM THIS DATE:
Your body doesn't lie: People ignore political ads of candidates they oppose
2012-09-17
COLUMBUS, Ohio - A recent study examined people's bodily responses while watching presidential campaign ads - and discovered another way that people avoid political information that challenges their beliefs.
In the last days of the 2008 campaign, researchers had people watch a variety of actual ads for Republican presidential candidate John McCain and his Democratic rival Barack Obama while the viewers' heart rates, skin conductance and activation of facial muscles were monitored.
The results showed that partisan participants reacted strongly to ads featuring their ...
Mobile phones and wireless networks: No evidence of health risk found
2012-09-17
There is no scientific evidence that low-level electromagnetic field exposure from mobile phones and other transmitting devices causes adverse health effects, according to a report presented by a Norwegian Expert Committee. In addition, the Committee provides advice to authorities about risk management and regulatory practice.
The Committee has assessed the health hazards from low-level electromagnetic fields generated by radio transmitters. These electromagnetic fields are found around mobile phones, wireless phones and networks, mobile phone base stations, broadcasting ...
At the right place at the right time -- new insights into muscle stem cells
2012-09-17
Muscles have a pool of stem cells which provides a source for muscle growth and for regeneration of injured muscles. The stem cells must reside in special niches of the muscle for efficient growth and repair. The developmental biologists Dr. Dominique Bröhl and Prof. Carmen Birchmeier of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch have elucidated how these stem cells colonize these niches. At the same time, they show that the stem cells weaken when, due to a mutation, they locate outside of the muscle fibers instead of in their stem cell niches (Developmental ...
Added benefit of Cannabis sativa for spasticity due to multiple sclerosis is not proven
2012-09-17
An extract from the plant Cannabis sativa (trade name Sativex®) was approved in May 2011 for patients suffering from moderate to severe spastic paralysis and muscle spasms due to multiple sclerosis (MS). In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether the new drug, which is used as a mouth spray, offers an added benefit over the optimized standard therapy. However, no such added benefit can be inferred from the dossier, ...
Rapid intensification of global struggle for land
2012-09-17
The earth's limited surface is expected to stretch to everything: food for soon to be nine billion people, feed for our beef cattle and fowl, fuel for our cars, forests for our paper, cotton for our clothes. What is more, the earth's forests are preferably to be left untouched to stabilise the climate. Human ecologist and economist Kenneth Hermele will shortly be defending a thesis at Lund University, Sweden, in which he demonstrates that the struggle for land is intensifying rapidly.
Kenneth Hermele has conducted field studies in Brazil, where sugar cane has been cultivated ...
Children evaluate educational games
2012-09-17
Is it possible to create suitable and amusing educational computer games? Can you use qualities from other types of games? And what do the children really think of these kinds of games? Wolmet Barendregt from The University of Gothenburg, conducts research on children's game playing, how we can support learning with design and include the children in the design process.
And Wolmet Barendregt certainly involves the children very much in her research. During the Science Festival's school program in April this year, over a hundred preschool children attended a creative game ...
Spacetime ripples from dying black holes could help reveal how they formed
2012-09-17
Researchers from Cardiff University have discovered a new property of black holes: their dying tones could reveal the cosmic crash that produced them.
Black holes are regions of space where gravity is so strong that not even light can escape and so isolated black holes are truly dark objects and don't emit any form of radiation.
However, black holes that get deformed, because of other black holes or stars crashing into them, are known to emit a new sort of radiation, called gravitational waves, which Einstein predicted nearly a hundred years ago.
Gravitational waves ...
Cardiff scientists bid to develop anthrax vaccine to counteract world bioterrorism threat
2012-09-17
A team of Cardiff University scientists is leading new research to develop a vaccine against anthrax to help counteract the threat of bioterrorism.
Working with scientists from the Republic of Georgia, Turkey and the USA, Professor Les Baillie from Cardiff University's School of Pharmacy and Pharmaceutical Sciences is leading a NATO project to tackle the potential misuse of anthrax.
"Currently the majority of the world's population is susceptible to infection with Bacillus anthracis the bacterium which causes anthrax," according to Professor Baillie, who leads ...
Proof of added benefit of apixaban in hip replacement
2012-09-17
The clot-inhibiting drug apixaban (trade name: Eliquis®) was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined the added benefit of apixaban.
IQWiG found proof of minor added benefit for adult patients who had undergone hip replacement: symptomatic clots in the deep veins of the leg occurred less frequently with ...
Behavior issues are a bigger headache for children with migraines
2012-09-17
Los Angeles, (17 September 2012). Kids who get migraine headaches are much more likely than other children to also have behavioral difficulties, including social and attention issues, and anxiety and depression. The more frequent the headaches, the greater the effect, according to research out now in the journal Cephalagia, published by SAGE.
Marco Arruda, director of the Glia Institute in São Paulo, Brazil, together with Marcelo Bigal of the Albert Einstein College of Medicine in New York studied 1,856 Brazilian children aged 5 to 11. The authors say that this is the ...